Matches in Nanopublications for { ?s ?p "[Prognostic markers in diffuse gliomas include IDH mutation, 1p/19q codeletion, and MGMT methylation, and MGMT is also a predictive marker in elderly patients with glioblastoma treated with temozolomide monotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP555249.RAVQRrSxlVyno3qly8blN3FcBejYtLnnE6mFyl8WWdBSA130_assertion description "[Prognostic markers in diffuse gliomas include IDH mutation, 1p/19q codeletion, and MGMT methylation, and MGMT is also a predictive marker in elderly patients with glioblastoma treated with temozolomide monotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP555249.RAVQRrSxlVyno3qly8blN3FcBejYtLnnE6mFyl8WWdBSA130_provenance.
- assertion description "[Prognostic markers in diffuse gliomas include IDH mutation, 1p/19q codeletion, and MGMT methylation, and MGMT is also a predictive marker in elderly patients with glioblastoma treated with temozolomide monotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Prognostic markers in diffuse gliomas include IDH mutation, 1p/19q codeletion, and MGMT methylation, and MGMT is also a predictive marker in elderly patients with glioblastoma treated with temozolomide monotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1244239.RAbg_GMHlt8OM-LSv18PAmoqZy8yr8rHl-FJ5DsQTkFwQ130_assertion description "[Prognostic markers in diffuse gliomas include IDH mutation, 1p/19q codeletion, and MGMT methylation, and MGMT is also a predictive marker in elderly patients with glioblastoma treated with temozolomide monotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244239.RAbg_GMHlt8OM-LSv18PAmoqZy8yr8rHl-FJ5DsQTkFwQ130_provenance.
- NP1244237.RAk6EfKHs3ao5XuY_drjQJLY6Yim9MSUP1mdteqBFJ3Hg130_assertion description "[Prognostic markers in diffuse gliomas include IDH mutation, 1p/19q codeletion, and MGMT methylation, and MGMT is also a predictive marker in elderly patients with glioblastoma treated with temozolomide monotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244237.RAk6EfKHs3ao5XuY_drjQJLY6Yim9MSUP1mdteqBFJ3Hg130_provenance.
- NP474822.RAMWfIWDgdsIVGCGKAOBDKR3UAHGkP0fo5h-x3DEtrOQU130_assertion description "[Prognostic markers in diffuse gliomas include IDH mutation, 1p/19q codeletion, and MGMT methylation, and MGMT is also a predictive marker in elderly patients with glioblastoma treated with temozolomide monotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP474822.RAMWfIWDgdsIVGCGKAOBDKR3UAHGkP0fo5h-x3DEtrOQU130_provenance.
- NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_assertion description "[Prognostic markers in diffuse gliomas include IDH mutation, 1p/19q codeletion, and MGMT methylation, and MGMT is also a predictive marker in elderly patients with glioblastoma treated with temozolomide monotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP475268.RAEhg0rKmnsjmYLE4iNX2vzW4U3SoS7TkK3xzsW0NA0eU130_provenance.
- NP1244233.RA6MPi4TREzDc0fuH4IlFlucvKsGm-tk5nuTIze25g-bw130_assertion description "[Prognostic markers in diffuse gliomas include IDH mutation, 1p/19q codeletion, and MGMT methylation, and MGMT is also a predictive marker in elderly patients with glioblastoma treated with temozolomide monotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244233.RA6MPi4TREzDc0fuH4IlFlucvKsGm-tk5nuTIze25g-bw130_provenance.